OGEN logo

Oragenics (OGEN)

Profile

Full Name

Oragenics, Inc.

Ticker Symbol

OGEN

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 25, 2004

Indexes

Not included

Website

http://www.oragenics.com

Employees

3

Key Details

Price

$0.18(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.60(+82.57% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.18
OGEN price is $0.18

30-Day Relative Volume

0.54
OGEN 30-day relative volume is 0.54

Price Performance

Price Most recent change

0%
OGEN {parameterFullLabel} has remained unchanged on Apr 17, 2025

Price YTD change

-51.35%
OGEN price is down -51.35% since January 1st

Price 1-year change

-83.33%
OGEN price is down -83.33% year-on-year

Price 3-year change

-99.14%
OGEN price is down -99.14% over the past 3 years

Price Range

Price All-time high

$54000.00
OGEN price is currently -100.00% below its historical high of $54000.00

Price 3-year low

$0.16
OGEN price is currently +12.50% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.87M
OGEN market capitalization is $3.87 million

Market cap 3-year change

-90.51%
OGEN market capitalization is down -90.51% over the past 3 years

Market cap All-time high

$155.16M
OGEN market capitalization is currently -97.51% below its historical high of $155.16 million

Market cap sector rank

11.11%
OGEN market capitalization is higher than 11.11% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+379.28%
OGEN shares outstanding is up +379.28% year-on-year

Shares Outstanding 3-Year Change

+1007.03%
OGEN shares outstanding is up +1007.03% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.91
OGEN beta is 0.91

200-day SMA

$0.50
OGEN price is currently -64.29% below its 200-day simple moving average

50-day SMA

$0.25
OGEN price is currently -28.00% below its 50-day simple moving average

RSI

34.12
OGEN 14-day relative strength index is 34.12

Volume

0.54
OGEN 30-day relative volume is 0.54

ATR

$0.02
OGEN average true range is $0.02

10-day Historical Volatility

96.83%
OGEN 10-day historical volatility is 96.83%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
OGEN annual revenue value is unknown

Revenue Analysts estimate

-
OGEN annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
OGEN annual revenue 1-year change is unknown

Revenue Sector rank

-
OGEN annual revenue is unknown

EPS

EPS

-$1.60
OGEN annual earnings per share is -$1.60

EPS Analysts estimate

-
OGEN annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+82.57%
OGEN annual earnings per share is up +82.57% year-on-year

EPS Sector rank

43.66%
OGEN annual earnings per share is higher than 43.66% of companies in Healthcare sector

Profit

Gross profit

-
OGEN annual gross profit value is unknown

Gross margin

-
OGEN annual gross profit margin value is unknown

Operating profit

-$10.56M
OGEN annual operating income is -$10.56 million

Operating margin

-
OGEN annual operating profit margin value is unknown

Net income

-$10.57M
OGEN annual net profit is -$10.57 million

Net margin

-
OGEN annual net profit margin value is unknown

Expenses

Total expenses

$10.56M
OGEN annual total expenses is $10.56 million

Operating expenses

$10.56M
OGEN annual total operating expenses is $10.56 million

Cost of goods sold

-
OGEN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$6.44M
OGEN annual SGA is $6.44 million

Depreciation and amortization

$0.00
OGEN annual depreciation & amortization is $0.00

Interest expense

$29.80K
OGEN annual interest expense is $29.80 thousand

Income tax

$0.00
OGEN annual income tax is $0.00

EBIT & EBITDA

EBIT

-$10.54M
OGEN annual earnings before interest & taxes is -$10.54 million

EBITDA

-$10.54M
OGEN annual EBITDA is -$10.54 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.47M
OGEN annual total assets is $1.47 million

Non current assets

$0.00
OGEN annual long term assets is $0.00

Current assets

$1.47M
OGEN annual total current assets is $1.47 million

Cash and cash equivalents

$864.80K
OGEN annual cash & cash equivalents is $864.80 thousand

Accounts receivable

-
OGEN annual accounts receivable value is unknown

Inventory

-
OGEN annual inventory value is unknown

Liabilities

Total liabilities

$1.68M
OGEN annual total liabilities is $1.68 million

Long term liabilities

$0.00
OGEN annual total long term liabilities is $0.00

Current liabilities

$1.68M
OGEN annual total current liabilities is $1.68 million

Accounts payable

$1.14M
OGEN annual accounts payable is $1.14 million

Debt

Total debt

$328.50K
OGEN annual total debt is $328.50 thousand

Total debt 1-year change

+1.86%
OGEN annual total debt is up +1.86% year-on-year

Long term debt

-
OGEN annual long term debt value is unknown

Short term debt

$328.50K
OGEN annual short term debt is $328.50 thousand

Equity & Capital

Shareholders equity

-$211.90K
OGEN annual stockholders equity is -$211.90 thousand

Book value

-$211.90K
OGEN annual book value is -$211.90 thousand

Retained earnings

-$216.79M
OGEN annual retained earnings is -$216.79 million

Working capital

-$211.90K
OGEN annual working capital is -$211.90 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$8.60M
OGEN annual cash flow from operations is -$8.60 million

Cash from operations 1-year change

-17.92%
OGEN annual cash flow from operations is down -17.92% year-on-year

Cash from investing

$0.00
OGEN annual cash flow from investing activities is $0.00

Cash from investing 1-year change

+100%
OGEN annual cash flow from investing activities is up +100% year-on-year

Cash from financing

$5.98M
OGEN annual cash flow from financing activities is $5.98 million

Cash from financing 1-year change

+2005.92%
OGEN annual cash flow from financing activities is up +2005.92% year-on-year

CAPEX

CAPEX

-
OGEN annual capital expenditures value is unknown

CAPEX 1-year change

-
OGEN annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$8.60M
OGEN annual free cash flow is -$8.60 million

Free cash flow 1-year change

-3.7%
OGEN annual free cash flow is down -3.7% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
OGEN annual gross profit margin value is unknown

Operating margin

-
OGEN annual operating profit margin value is unknown

Net margin

-
OGEN annual net profit margin value is unknown

ROA & ROE

ROA

-717.68%
OGEN annual return on assets is -717.68%

ROE

4987.21%
OGEN annual return on equity is 4987.21%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OGEN price to earnings ratio value is unknown

PE ratio Sector rank

-
OGEN price to earnings ratio is unknown

PB Ratio

PB ratio

-18.24
OGEN price to book ratio is -18.24

PB ratio Sector rank

1.98%
OGEN price to book ratio is higher than 1.98% of companies in Healthcare sector

PS Ratio

PS ratio

-
OGEN price to sales ratio value is unknown

PS ratio Sector rank

-
OGEN price to sales ratio is unknown

Enterprise value

Enterprise value

$3.33M
OGEN enterprise value is $3.33 million

Enterprise value Sector rank

16.61%
OGEN enterprise value is higher than 16.61% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.32
OGEN EV/EBITDA is -0.32

EV/EBITDA Sector rank

55.53%
OGEN EV/EBITDA is higher than 55.53% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.87
OGEN annual current ratio is 0.87

Quick ratio

-
OGEN annual quick ratio value is unknown

Leverage

Debt to equity

-1.55
OGEN annual debt to equity ratio is -1.55

Interest coverage ratio

-353.63
OGEN annual interest coverage ratio is -353.63

Risk & Stability

Piotroski F-Score

-
OGEN piotroski f-score value is unknown

Altman Z-Score

-
OGEN altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Jun 3, 21 Goldman Sachs
Neutral
Apr 16, 20 H.C. Wainwright
Neutral
Nov 15, 19 UBS
Neutral
Apr 26, 19 H.C. Wainwright
Buy

Institutional Ownership

Similar stocks

PRFX logo
PainReform (PRFX)
SONN logo
Sonnet BioTherapeutics Holdings (SONN)
CHEK logo
Check-Cap (CHEK)
TOVX logo
Theriva Biologics (TOVX)
DRMA logo
Dermata Therapeutics (DRMA)
RDHL logo
RedHill Biopharma (RDHL)
TCRT logo
Alaunos Therapeutics (TCRT)
RHE logo
Regional Health Properties (RHE)
XBIO logo
Xenetic Biosciences (XBIO)
  • What is the ticker symbol for Oragenics?
  • Does Oragenics pay dividends?
  • What sector is Oragenics in?
  • What industry is Oragenics in?
  • What country is Oragenics based in?
  • When did Oragenics go public?
  • Is Oragenics in the S&P 500?
  • Is Oragenics in the NASDAQ 100?
  • Is Oragenics in the Dow Jones?
  • When was Oragenics's last earnings report?
  • When does Oragenics report earnings?
  • Should I buy Oragenics stock now?

What is the ticker symbol for Oragenics?

The ticker symbol for Oragenics is NYSE American:OGEN

Does Oragenics pay dividends?

No, Oragenics does not pay dividends

What sector is Oragenics in?

Oragenics is in the Healthcare sector

What industry is Oragenics in?

Oragenics is in the Biotechnology industry

What country is Oragenics based in?

Oragenics is headquartered in United States

When did Oragenics go public?

Oragenics's initial public offering (IPO) was on February 25, 2004

Is Oragenics in the S&P 500?

No, Oragenics is not included in the S&P 500 index

Is Oragenics in the NASDAQ 100?

No, Oragenics is not included in the NASDAQ 100 index

Is Oragenics in the Dow Jones?

No, Oragenics is not included in the Dow Jones index

When was Oragenics's last earnings report?

Oragenics's most recent earnings report was on Nov 13, 2024

When does Oragenics report earnings?

The next expected earnings date for Oragenics is May 15, 2025

Should I buy Oragenics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page